You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
清晰醫療(01406.HK)預計年度盈利不少於約1300萬港元
格隆匯 05-20 17:24

格隆匯5月20日丨清晰醫療(01406.HK)公佈,公司擁有人應占溢利預期會由截至2021年3月31日止年度的約3580萬港元,下降至截至2022年3月31日止年度的不少於約1300萬港元,預期跌幅為約63.7%。

以下因素為錄得該預期跌幅的主要原因:

1)受香港新冠病毒(COVID–19)第五波疫情爆發拖累,營商環境疲弱,令(i)2022年2月及3月的收入較2021年同期減少;及(ii)2022年2月及3月的平均每月收入較2021年最後一季減少;

2)公司於截至2021年3月31日止年度獲得一筆約490萬港元的一次性非經常性政府補助,惟於截至2022年3月31日止年度則並無類似補助;

3)因公司上市而於截至2022年3月31日止年度產生更多開支;及

4)醫生人數由2021年3月31日的9名增至2022年3月31日的11名,令截至2022年3月31日止年度集團已向醫生支付的顧問費增加。

於未計及一次性非經常性政府補助,以及於截至2021年及2022年3月31日止年度產生的上市開支所帶來的影響下,集團預期公司擁有人應占溢利會由截至2021年3月31日止年度的約3950萬港元,下降至截至2022年3月31日止年度的約3000萬港元,預期跌幅為約24.1%。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account